Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Harrow Health, Inc. (HROW)
USD42.28
+0.91 (+2.19%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
102 Woodmont Boulevard 37205
Nashville, TN, US
Nashville, TN, US
CEO
Mark L. Baum
Website
harrowinc.com
IPO
2007-09-28
CIK 1360214 ISIN US4158581094
Also trades on
NASDAQ Global Market · HROW (USD)
NASDAQ Global Market · HROWL (USD)
NASDAQ Global Market · HROWM (USD)
Description
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD42.28
+0.91 (+2.19%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
797.0K
Beta
0.28
Float Shares
27.42M
Free Float %
73.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -23.69% | -27.89% | -19.20% | -38.39% | -24.48% | -40.76% | +8.89% | +31.72% | +219.71% | +686.72% | +13.35% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
42.28
Low
63.00
+49.0%
Consensus
66.50
+57.3%
Median
66.50
+57.3%
High
70.00
+65.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
66.50
+57.3%
|
| Last Year | 7 |
71.57
+69.3%
|
| All Time | 13 |
58.00
+37.2%
|
Quality scores
Altman Z-Score
2.58
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+36.4% ★ Q1'26: -7.6% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+71.4% ★ Q1'26: -48.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+11.0% Q1'26: -20.8% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+13.4% ★ Q1'26: +0.0% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+15.8% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+3.1% Q1'26: +3.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×4.49× Q1'26: -3.40× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 2 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.72M
est: 9.73M (-0.1%)
|
19.94M
est: 19.65M (+1.5%)
|
26.77M
est: 27.39M (-2.2%)
|
41.37M
est: 40.94M (+1.0%)
|
51.17M
est: 52.24M (-2.1%)
|
48.87M
est: 48.74M (+0.3%)
|
72.48M
est: 71.64M (+1.2%)
|
88.60M
est: 89.54M (-1.1%)
|
130.19M
est: 138.68M (-6.1%)
|
199.61M
est: 194.57M (+2.6%)
|
272.30M
est: 273.82M (-0.6%)
|
351.38M
350.64M – 351.82M
+28.3% YoY
|
529.77M
515.95M – 543.57M
+50.8% YoY
|
743.70M
735.54M – 751.86M
+40.4% YoY
|
971.93M
938.12M – 1.01B
+30.7% YoY
|
1.12B
1.08B – 1.16B
+15.0% YoY
|
| EBITDA |
-14.21M
est: 739.9K (-2,020.8%)
|
-14.17M
est: 1.49M (-1,048.6%)
|
-10.40M
est: 2.08M (-599.3%)
|
-3.37M
est: 3.11M (-208.4%)
|
1.91M
est: 3.97M (-52.0%)
|
2.62M
est: 3.71M (-29.4%)
|
5.10M
est: 5.45M (-6.3%)
|
4.75M
est: 6.81M (-30.2%)
|
11.95M
est: 14.77M (-19.1%)
|
22.13M
est: 20.73M (+6.8%)
|
56.08M
est: 29.17M (+92.3%)
|
37.43M
37.35M – 37.48M
+28.3% YoY
|
56.43M
54.96M – 57.90M
+50.8% YoY
|
79.22M
78.35M – 80.09M
+40.4% YoY
|
103.53M
99.93M – 107.43M
+30.7% YoY
|
119.04M
114.90M – 123.52M
+15.0% YoY
|
| EBIT |
-14.82M
est: 262.8K (-5,739.5%)
|
-15.46M
est: 530.8K (-3,013.6%)
|
-12.16M
est: 739.8K (-1,744.0%)
|
-5.22M
est: 1.11M (-571.7%)
|
-706.0K
est: 1.41M (-150.0%)
|
748.0K
est: 1.32M (-43.2%)
|
3.36M
est: 1.94M (+73.8%)
|
1.92M
est: 2.42M (-20.7%)
|
811.0K
est: 7.03M (-88.5%)
|
9.08M
est: 9.86M (-8.0%)
|
36.40M
est: 13.88M (+162.3%)
|
17.81M
17.77M – 17.83M
+28.3% YoY
|
26.85M
26.15M – 27.55M
+50.8% YoY
|
37.70M
37.28M – 38.11M
+40.4% YoY
|
49.27M
47.55M – 51.12M
+30.7% YoY
|
56.64M
54.67M – 58.78M
+15.0% YoY
|
| Net Income |
-15.90M
est: -39.93M (+60.2%)
|
-19.09M
est: -47.06M (+59.4%)
|
-11.99M
est: -30.66M (+60.9%)
|
14.63M
est: -9.27M (+257.8%)
|
168.0K
est: -3.21M (+105.2%)
|
-3.36M
est: -3.21M (-4.6%)
|
-18.01M
est: -17.23M (-4.5%)
|
-14.09M
est: -23.89M (+41.0%)
|
-24.41M
est: -34.94M (+30.1%)
|
-17.48M
est: -21.70M (+19.4%)
|
-5.14M
est: -5.14M (+0.0%)
|
17.96M
7.22M – 22.02M
+449.4% YoY
|
101.17M
64.46M – 121.50M
+463.4% YoY
|
180.90M
107.34M – 196.30M
+78.8% YoY
|
268.72M
256.56M – 281.89M
+48.5% YoY
|
323.12M
308.51M – 338.96M
+20.2% YoY
|
| SGA |
19.00M
est: 1.07M (+1,677.3%)
|
24.95M
est: 2.16M (+1,055.8%)
|
25.02M
est: 3.01M (+731.4%)
|
29.24M
est: 4.50M (+550.0%)
|
33.10M
est: 5.74M (+476.6%)
|
—
est: 5.35M (-100.0%)
|
39.82M
est: 7.87M (+405.8%)
|
—
est: 9.84M (-100.0%)
|
—
est: 30.81M (-100.0%)
|
—
est: 43.23M (-100.0%)
|
152.91M
est: 60.84M (+151.4%)
|
78.07M
77.91M – 78.17M
+28.3% YoY
|
117.70M
114.63M – 120.77M
+50.8% YoY
|
165.24M
163.42M – 167.05M
+40.4% YoY
|
215.95M
208.43M – 224.09M
+30.7% YoY
|
248.29M
239.65M – 257.65M
+15.0% YoY
|
| EPS |
-1.66
est: -1.12 (-48.2%)
|
-1.50
est: -1.32 (-13.6%)
|
-0.60
est: -0.86 (+30.2%)
|
0.67
est: -0.26 (+357.7%)
|
0.01
est: -0.09 (+111.1%)
|
-0.13
est: -0.09 (-44.4%)
|
-0.69
est: -0.48 (-42.8%)
|
-0.51
est: -0.67 (+23.9%)
|
-0.75
est: -0.92 (+18.8%)
|
-0.49
est: -0.58 (+15.5%)
|
-0.14
est: 0.06 (-334.7%)
|
0.47
0.20 – 0.60
+689.9% YoY
|
2.63
1.75 – 3.31
+457.0% YoY
|
4.13
2.92 – 5.34
+57.3% YoY
|
7.31
6.98 – 7.67
+77.0% YoY
|
8.79
8.39 – 9.22
+20.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-17 | BTIG | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
19.37M
OE per share TTM
0.50
Owner's Yield
1.38%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
105
Total invested
179.99M
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mark L. Baum | 16.33M | 53.90% | 354.2K | 15.98M | 354.2K | 10.00 | IN | U.S.A | 2012-05-02 | ↗ |
| 2 | Robert Kammer | 16.10M | 53.60% | 117.0K | 15.98M | 117.0K | 10.00 | IN | U.S.A | 2012-05-02 | ↗ |
| 3 | DermaStar International, LLC | 15.98M | 53.40% | — | 15.98M | — | 10.00 | OO | Nevada | 2012-05-02 | ↗ |
| 4 | Professional Compounding Centers of America, Inc. 74-2188864 | 4.16M | 12.30% | 4.16M | — | 4.16M | 4.16M | CO | 9901 S. Wilcrest Dr., Houston, TX, 77099 | 2012-09-13 | ↗ |
| 5 | Private Capital Management, LLC (46-3167283) | 3.63M | 10.34% | 2.08M | 1.55M | 2.08M | 1.55M | IA | Delaware | 2024-01-09 | ↗ |
| 6 | Imprimis Pharmaceuticals, Inc. | 3.50M | 20.70% | 3.50M | — | 3.50M | — | CO | State of Delaware | 2018-11-23 | ↗ |
| 7 | (1) BlackRock, Inc. | 2.22M | 6.30% | 2.18M | — | 2.22M | — | HC | Delaware | 2024-01-29 | ↗ |
| 8 | Alexej Ladonnikov | 1.98M | 8.94% | 1.98M | — | 1.98M | 1.98M | IN | U.S.A | 2012-04-30 | ↗ |
| 9 | Ophir Global Opportunities Fund | 1.91M | 7.08% | 1.91M | — | 1.91M | — | OO | Australia | 2022-02-14 | ↗ |
| 10 | The Vanguard Group - 23-1945930 | 1.81M | 5.15% | — | 54.8K | 1.73M | 79.6K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 11 | Jeffrey J. Abrams | 1.56M | 11.40% | — | — | — | 1.56M | IN | OR PLACE OF ORGANIZATION | 2008-02-14 | ↗ |
| 12 | The Abrams Family Trust | 1.56M | 11.40% | — | — | — | 1.56M | OO | OR PLACE OF ORGANIZATION | 2008-02-14 | ↗ |
| 13 | Brett Conrad | 1.42M | 7.10% | 1.42M | — | 1.42M | — | IA | Longboard Capital Advisors, LLC – Delaware Brett Conrad – USA | 2017-04-19 | ↗ |
| 14 | 13-3127734 | 1.20M | 4.46% | 1.12M | — | 1.20M | — | HC | Delaware | 2022-02-10 | ↗ |
| 15 | 26-0385758 | 1.20M | 4.46% | 1.12M | — | 1.20M | — | IA | Delaware | 2022-02-10 | ↗ |
| 16 | Joseph Grasela | 1.17M | 8.50% | — | — | 1.17M | — | IN | OR PLACE OF ORGANIZATION | 2008-02-14 | ↗ |
| 17 | Dr. Robert J. Kammer | 1.02M | 11.22% | 1.02M | — | 1.02M | 10.00 | IN | U.S.A. | 2013-08-16 | ↗ |
| 18 | Marathon Asset Management, L.P. | 833.3K | 4.50% | 833.3K | — | 833.3K | — | IA | Delaware United States | 2017-02-14 | ↗ |
| 19 | Donald Miloni | 747.1K | 7.82% | 468.6K | 278.5K | 468.6K | 278.5K | IN | USA | 2015-05-20 | ↗ |
| 20 | James Silverman | 720.0K | 3.87% | — | — | — | 720.0K | IN | Opaleye Management Inc. | 2017-02-23 | ↗ |
| 21 | Opaleye Management Inc. | 9.00 | 5.11% | — | 1.08M | — | 1.08M | CO | Massachusetts | 2018-09-07 | ↗ |
| 22 | Opaleye, L.P. | 9.00 | 5.11% | — | 1.08M | — | 1.08M | PN | Massachusetts | 2018-09-07 | ↗ |
| 23 | James E. Besser | — | 0.00% | — | — | — | — | IN | Delaware | 2016-02-16 | ↗ |
| 24 | Manchester Management Company, LLC | — | 0.00% | — | — | — | — | OO | Delaware | 2016-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
105
-119 vs prev Q
New positions
25
Closed positions
133
Increased
57
Reduced
26
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 94.0K +94.0K (+100.0%) | 4.60B +4.6B (+100.0%) | 0.25% +0.253 pp | 2.73% +2.735 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 2 | OPALEYE MANAGEMENT INC. | 3.91M +— (+0.0%) | 191.35M +3.2M (+1.7%) | 10.51% -0.102 pp | 25.24% -1.356 pp | USD7.12 +588.2% | 23 qtrs — |
| 3 | BLACKROCK, INC. | 2.57M +17.4K (+0.7%) | 125.85M +2.9M (+2.4%) | 6.91% -0.020 pp | 0.00% +0.000 pp | USD43.70 +12.1% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 1.92M +50.9K (+2.7%) | 94.16M +4.0M (+4.5%) | 5.17% +0.088 pp | 0.00% +0.000 pp | USD11.50 +326.1% | 28 qtrs — |
| 5 | PRIVATE CAPITAL MANAGEMENT, LLC | 1.84M -12.6K (-0.7%) | 90.31M +905.6K (+1.0%) | 4.96% -0.082 pp | 8.28% +0.292 pp | USD12.89 +280.1% | 15 qtrs — |
| 6 | LUXOR CAPITAL GROUP, LP | 917.5K +610.2K (+198.5%) | 44.96M +30.2M (+203.6%) | 2.47% +1.635 pp | 3.44% +2.746 pp | USD48.73 +0.6% | 2 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 785.1K +9.4K (+1.2%) | 38.48M +1.1M (+2.9%) | 2.11% +0.005 pp | 0.00% +0.000 pp | USD15.64 +213.3% | 28 qtrs — |
| 8 | STATE STREET CORP | 783.7K -10.5K (-1.3%) | 38.40M +134.8K (+0.4%) | 2.11% -0.049 pp | 0.00% +0.000 pp | USD20.33 +141.0% | 27 qtrs — |
| 9 | ROYCE & ASSOCIATES LP | 509.7K -23.3K (-4.4%) | 24.98M -703.0K (-2.7%) | 1.37% -0.077 pp | 0.25% -0.003 pp | USD24.02 +104.0% | 11 qtrs — |
| 10 | PENN CAPITAL MANAGEMENT COMPANY, LLC | 392.1K +66.6K (+20.5%) | 19.26M +3.5M (+22.5%) | 1.06% +0.171 pp | 1.53% +0.327 pp | USD48.32 +1.4% | 2 qtrs — |
| 11 | DIMENSIONAL FUND ADVISORS LP | 370.5K +90.3K (+32.2%) | 18.16M +4.7M (+34.5%) | 1.00% +0.236 pp | 0.00% +0.001 pp | USD41.08 +19.3% | 3 qtrs — |
| 12 | GOLDMAN SACHS GROUP INC | 366.5K +80.4K (+28.1%) | 17.96M +4.2M (+30.3%) | 0.99% +0.209 pp | 0.00% +0.001 pp | USD44.15 +11.0% | 12 qtrs — |
| 13 | RICE HALL JAMES & ASSOCIATES, LLC | 362.0K +28.3K (+8.5%) | 17.74M +1.7M (+10.3%) | 0.97% +0.068 pp | 0.98% +0.100 pp | USD24.41 +100.7% | 10 qtrs — |
| 14 | NORTHERN TRUST CORP | 300.9K -16.5K (-5.2%) | 14.74M -547.2K (-3.6%) | 0.81% -0.053 pp | 0.00% 0.000 pp | USD16.89 +190.1% | 28 qtrs — |
| 15 | BRAIDWELL LP | 295.3K -47.1K (-13.8%) | 14.47M -2.0M (-12.3%) | 0.80% -0.136 pp | 0.46% -0.027 pp | USD30.84 +58.9% | 12 qtrs — |
| 16 | DIAMETRIC CAPITAL, LP | 278.1K +153.9K (+124.0%) | 13.63M +7.6M (+127.8%) | 0.75% +0.411 pp | 3.65% +1.434 pp | USD40.76 +20.2% | 28 qtrs — |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 272.6K -181.0 (-0.1%) | 13.36M +214.8K (+1.6%) | 0.73% -0.008 pp | 0.00% +0.000 pp | USD34.81 +40.8% | 23 qtrs — |
| 18 | NEW YORK STATE COMMON RETIREMENT FUND | 252.0K +38.2K (+17.9%) | 12.35M +2.0M (+19.9%) | 0.68% +0.097 pp | 0.02% +0.003 pp | USD47.66 +2.8% | 11 qtrs — |
| 19 | MORGAN STANLEY | 233.8K +92.7K (+65.7%) | 11.45M +4.7M (+68.5%) | 0.63% +0.246 pp | 0.00% +0.000 pp | USD40.88 +19.9% | 28 qtrs — |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 229.6K +56.8K (+32.9%) | 11.25M +2.9M (+35.1%) | 0.62% +0.148 pp | 0.00% +0.000 pp | USD36.93 +32.7% | 16 qtrs — |
| 21 | UBS GROUP AG | 222.4K +100.2K (+82.0%) | 10.90M +5.0M (+85.1%) | 0.60% +0.267 pp | 0.00% +0.001 pp | USD40.48 +21.0% | 28 qtrs — |
| 22 | STIFEL FINANCIAL CORP | 212.5K -15.2K (-6.7%) | 10.41M -558.2K (-5.1%) | 0.57% -0.047 pp | 0.01% -0.001 pp | USD15.75 +211.1% | 10 qtrs — |
| 23 | MARSHALL WACE, LLP | 200.3K -307.8K (-60.6%) | 9.82M -14.7M (-59.9%) | 0.54% -0.842 pp | 0.01% -0.016 pp | USD27.54 +77.9% | 4 qtrs — |
| 24 | IKARIAN CAPITAL, LLC | 183.3K +183.3K (+100.0%) | 8.98M +9.0M (+100.0%) | 0.49% +0.494 pp | 0.70% +0.701 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 25 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 181.4K +1.8K (+1.0%) | 8.89M +234.2K (+2.7%) | 0.49% +0.000 pp | 1.42% +0.039 pp | USD11.12 +340.6% | 24 qtrs — |
| 26 | FIRST TRUST ADVISORS LP | 152.2K -9.8K (-6.1%) | 7.46M -349.3K (-4.5%) | 0.41% -0.031 pp | 0.01% 0.000 pp | USD39.13 +25.2% | 3 qtrs — |
| 27 | INVESCO LTD. | 145.4K +38.3K (+35.7%) | 7.12M +2.0M (+38.0%) | 0.39% +0.100 pp | 0.00% +0.000 pp | USD35.76 +37.0% | 13 qtrs — |
| 28 | BOOTHBAY FUND MANAGEMENT, LLC | 145.2K +33.2K (+29.6%) | 7.11M +1.7M (+31.8%) | 0.39% +0.087 pp | 0.11% +0.028 pp | USD48.37 +1.3% | 5 qtrs — |
| 29 | JANE STREET GROUP, LLC | 142.9K +19.4K (+15.7%) | 7.00M +1.1M (+17.7%) | 0.38% +0.049 pp | 0.00% +0.000 pp | USD40.48 +21.0% | 6 qtrs — |
| 30 | BLACKHAWK CAPITAL PARTNERS LLC. | 134.8K +25.3K (+23.2%) | 6.60M +1.3M (+25.3%) | 0.36% +0.065 pp | 2.48% +0.429 pp | USD48.33 +1.4% | 2 qtrs — |
| 31 | CITADEL ADVISORS LLC | 121.5K -37.6K (-23.6%) | 5.95M -1.7M (-22.3%) | 0.33% -0.105 pp | 0.00% 0.000 pp | USD31.48 +55.7% | 14 qtrs — |
| 32 | WELLINGTON MANAGEMENT GROUP LLP | 109.6K -11.8K (-9.7%) | 5.37M -478.4K (-8.2%) | 0.30% -0.035 pp | 0.00% 0.000 pp | USD25.57 +91.6% | 13 qtrs — |
| 33 | GROUP ONE TRADING, L.P. | 108.6K -40.1K (-27.0%) | 5.32M -1.8M (-25.7%) | 0.29% -0.112 pp | 0.01% -0.003 pp | USD38.00 +28.9% | 12 qtrs — |
| 34 | WOODMONT INVESTMENT COUNSEL LLC | 105.3K +1.5K (+1.4%) | 5.16M +157.5K (+3.1%) | 0.28% +0.001 pp | 0.32% -0.008 pp | USD16.75 +192.5% | 10 qtrs — |
| 35 | RENAISSANCE TECHNOLOGIES LLC | 105.0K -13.1K (-11.1%) | 5.14M -546.9K (-9.6%) | 0.28% -0.038 pp | 0.01% +0.001 pp | USD6.22 +687.8% | 28 qtrs — |
| 36 | RUSSELL INVESTMENTS GROUP, LTD. | 103.9K +5.4K (+5.5%) | 5.09M +346.3K (+7.3%) | 0.28% +0.012 pp | 0.01% +0.000 pp | USD48.21 +1.6% | 6 qtrs — |
| 37 | CRAWFORD FUND MANAGEMENT, LLC | 103.4K +103.4K (+100.0%) | 5.07M +5.1M (+100.0%) | 0.28% +0.278 pp | 0.67% +0.668 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 38 | BANK OF AMERICA CORP /DE/ | 95.4K -17.8K (-15.8%) | 4.67M -780.9K (-14.3%) | 0.26% -0.051 pp | 0.00% +0.000 pp | USD32.29 +51.7% | 24 qtrs — |
| 39 | 12TH STREET ASSET MANAGEMENT COMPANY, LLC | 91.1K +91.1K (+100.0%) | 4.47M +4.5M (+100.0%) | 0.25% +0.245 pp | 0.74% +0.736 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 40 | LUMBARD & KELLNER, LLC | 88.3K -543.0 (-0.6%) | 4.33M +46.3K (+1.1%) | 0.24% -0.004 pp | 1.52% -0.059 pp | USD48.18 +1.7% | 2 qtrs — |
| 41 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 83.7K -3.6K (-4.2%) | 4.10M -106.4K (-2.5%) | 0.23% -0.012 pp | 0.02% -0.002 pp | USD21.51 +127.8% | 12 qtrs — |
| 42 | BANK OF NEW YORK MELLON CORP | 81.0K -9.0K (-10.0%) | 3.97M -367.9K (-8.5%) | 0.22% -0.027 pp | 0.00% 0.000 pp | USD15.80 +210.1% | 28 qtrs — |
| 43 | CAPTRUST FINANCIAL ADVISORS | 70.0K +376.0 (+0.5%) | 3.43M +75.5K (+2.3%) | 0.19% -0.001 pp | 0.01% 0.000 pp | USD13.40 +265.7% | 12 qtrs — |
| 44 | KENNEDY CAPITAL MANAGEMENT LLC | 67.2K -416.0 (-0.6%) | 3.29M +35.1K (+1.1%) | 0.18% -0.003 pp | 0.07% -0.002 pp | USD15.53 +215.5% | 10 qtrs — |
| 45 | STATE OF WISCONSIN INVESTMENT BOARD | 64.3K +42.6K (+196.9%) | 3.15M +2.1M (+202.0%) | 0.17% +0.114 pp | 0.01% +0.005 pp | USD37.58 +30.4% | 11 qtrs — |
| 46 | NUVEEN, LLC | 63.0K -994.0 (-1.6%) | 3.09M +3.8K (+0.1%) | 0.17% -0.004 pp | 0.00% +0.000 pp | USD26.60 +84.2% | 4 qtrs — |
| 47 | SWISS NATIONAL BANK | 62.1K +2.0K (+3.3%) | 3.04M +147.3K (+5.1%) | 0.17% +0.004 pp | 0.00% +0.000 pp | USD44.66 +9.7% | 11 qtrs — |
| 48 | DEUTSCHE BANK AG\ | 61.7K +992.0 (+1.6%) | 3.02M +98.4K (+3.4%) | 0.17% +0.001 pp | 0.00% +0.000 pp | USD22.86 +114.3% | 23 qtrs — |
| 49 | SQUAREPOINT OPS LLC | 59.1K +8.1K (+15.8%) | 2.90M +437.9K (+17.8%) | 0.16% +0.020 pp | 0.00% +0.001 pp | USD43.58 +12.4% | 12 qtrs — |
| 50 | BARCLAYS PLC | 56.4K +3.8K (+7.2%) | 2.76M +398.0K (+16.8%) | 0.15% +0.009 pp | 0.00% +0.000 pp | USD35.53 +37.9% | 19 qtrs — |
| 51 | UBS ASSET MANAGEMENT AMERICAS INC | 56.2K +2.3K (+4.2%) | 2.75M +155.3K (+6.0%) | 0.15% +0.005 pp | 0.00% +0.000 pp | USD37.16 +31.9% | 6 qtrs — |
| 52 | IMC-CHICAGO, LLC | 53.3K +28.5K (+114.4%) | 2.61M +1.4M (+118.1%) | 0.14% +0.076 pp | 0.00% +0.001 pp | USD38.61 +26.9% | 4 qtrs — |
| 53 | MILITIA CAPITAL PARTNERS, LP | 47.0K +47.0K (+100.0%) | 2.30M +2.3M (+100.0%) | 0.13% +0.127 pp | 0.85% +0.851 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 54 | PRELUDE CAPITAL MANAGEMENT, LLC | 44.5K +10.2K (+29.6%) | 2.18M +526.6K (+31.8%) | 0.12% +0.027 pp | 0.16% +0.031 pp | USD27.66 +77.2% | 28 qtrs — |
| 55 | HRT FINANCIAL LP | 43.7K -44.0K (-50.2%) | 2.14M -2.1M (-49.4%) | 0.12% -0.121 pp | 0.01% -0.009 pp | USD46.04 +6.4% | 5 qtrs — |
| 56 | EQUITABLE TRUST CO | 43.2K +— (+0.0%) | 2.12M +35.5K (+1.7%) | 0.12% -0.001 pp | 0.09% -0.001 pp | USD13.16 +272.3% | 15 qtrs — |
| 57 | BARD ASSOCIATES INC | 40.7K -1.3K (-3.0%) | 1.99M -27.2K (-1.3%) | 0.11% -0.005 pp | 0.51% -0.024 pp | USD6.64 +638.0% | 28 qtrs — |
| 58 | WELLS FARGO & COMPANY/MN | 39.1K +14.6K (+59.8%) | 1.92M +737.0K (+62.5%) | 0.11% +0.039 pp | 0.00% +0.000 pp | USD36.49 +34.3% | 15 qtrs — |
| 59 | D.A. DAVIDSON & CO. | 39.0K -6.6K (-14.4%) | 1.91M -284.1K (-12.9%) | 0.11% -0.019 pp | 0.01% -0.002 pp | USD15.75 +211.1% | 11 qtrs — |
| 60 | PANAGORA ASSET MANAGEMENT INC | 38.8K +38.8K (+100.0%) | 1.90M +1.9M (+100.0%) | 0.10% +0.105 pp | 0.01% +0.007 pp | USD49.00 +0.0% | 6 qtrs — |
| 61 | RHUMBLINE ADVISERS | 37.5K -8.3K (-18.1%) | 1.84M -368.6K (-16.7%) | 0.10% -0.024 pp | 0.00% 0.000 pp | USD19.81 +147.3% | 11 qtrs — |
| 62 | STANSBERRY ASSET MANAGEMENT, LLC | 37.2K -3.0K (-7.5%) | 1.82M -114.9K (-5.9%) | 0.10% -0.009 pp | 0.18% -0.018 pp | USD25.15 +94.8% | 18 qtrs — |
| 63 | JPMORGAN CHASE & CO | 34.9K -1.3K (-3.5%) | 1.71M -32.1K (-1.8%) | 0.09% -0.004 pp | 0.00% +0.000 pp | USD31.02 +58.0% | 28 qtrs — |
| 64 | BIRCHVIEW CAPITAL, LP | 34.0K -6.0K (-15.0%) | 1.67M -261.2K (-13.6%) | 0.09% -0.017 pp | 0.98% -0.480 pp | USD4.66 +951.5% | 28 qtrs — |
| 65 | ADVISOR GROUP HOLDINGS, INC. | 32.0K -7.2K (-18.3%) | 1.57M -12.1K (-0.8%) | 0.09% -0.020 pp | 0.00% +0.000 pp | USD33.56 +46.0% | 24 qtrs — |
| 66 | LPL FINANCIAL LLC | 30.8K +6.5K (+26.7%) | 1.51M +338.3K (+28.8%) | 0.08% +0.017 pp | 0.00% +0.000 pp | USD24.04 +103.8% | 11 qtrs — |
| 67 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 30.8K -27.0 (-0.1%) | 1.51M +24.0K (+1.6%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD43.44 +12.8% | 11 qtrs — |
| 68 | LEGAL & GENERAL GROUP PLC | 30.5K -138.0 (-0.5%) | 1.49M +18.3K (+1.2%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD40.47 +21.1% | 11 qtrs — |
| 69 | ALLIANCEBERNSTEIN L.P. | 29.5K +— (+0.0%) | 1.45M +24.2K (+1.7%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD18.31 +167.6% | 11 qtrs — |
| 70 | KORNITZER CAPITAL MANAGEMENT INC /KS | 28.1K -1.9K (-6.3%) | 1.38M -67.6K (-4.7%) | 0.08% -0.006 pp | 0.03% 0.000 pp | USD30.54 +60.4% | 3 qtrs — |
| 71 | BLAIR WILLIAM & CO/IL | 27.4K +27.4K (+100.0%) | 1.34M +1.3M (+100.0%) | 0.07% +0.074 pp | 0.00% +0.004 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 72 | AMERICAN CENTURY COMPANIES INC | 27.0K +9.6K (+55.2%) | 1.32M +484.6K (+57.8%) | 0.07% +0.025 pp | 0.00% +0.000 pp | USD48.47 +1.1% | 5 qtrs — |
| 73 | GREAT LAKES ADVISORS, LLC | 27.0K +— (+0.0%) | 1.32M +22.1K (+1.7%) | 0.07% -0.001 pp | 0.01% 0.000 pp | USD34.11 +43.7% | 5 qtrs — |
| 74 | FRANKLIN RESOURCES INC | 26.1K -437.0 (-1.6%) | 1.28M +341.0 (+0.0%) | 0.07% -0.002 pp | 0.00% +0.000 pp | USD23.17 +111.5% | 18 qtrs — |
| 75 | PRICE T ROWE ASSOCIATES INC /MD/ | 25.4K +1.2K (+4.8%) | 1.25M +77.0K (+6.6%) | 0.07% +0.003 pp | 0.00% +0.000 pp | USD19.66 +149.2% | 20 qtrs — |
| 76 | CITIGROUP INC | 25.3K +11.4K (+82.1%) | 1.24M +570.6K (+85.2%) | 0.07% +0.030 pp | 0.00% +0.000 pp | USD40.88 +19.9% | 17 qtrs — |
| 77 | CREATIVE PLANNING | 24.8K -8.3K (-25.2%) | 1.22M -381.9K (-23.9%) | 0.07% -0.023 pp | 0.00% 0.000 pp | USD24.07 +103.6% | 9 qtrs — |
| 78 | CETERA INVESTMENT ADVISERS | 23.3K +597.0 (+2.6%) | 1.14M +47.8K (+4.4%) | 0.06% +0.001 pp | 0.00% +0.000 pp | USD48.20 +1.7% | 2 qtrs — |
| 79 | VERITION FUND MANAGEMENT LLC | 22.1K +16.0K (+260.0%) | 1.09M +788.7K (+266.1%) | 0.06% +0.043 pp | 0.00% +0.003 pp | USD48.77 +0.5% | 6 qtrs — |
| 80 | COLONY GROUP, LLC | 21.2K +21.2K (+100.0%) | 1.04M +1.0M (+100.0%) | 0.06% +0.057 pp | 0.00% +0.001 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 81 | LIDO ADVISORS, LLC | 19.5K +— (+0.0%) | 938.8K +— (+0.0%) | 0.05% -0.001 pp | 0.00% 0.000 pp | USD24.51 +99.9% | 12 qtrs — |
| 82 | ELLSWORTH ADVISORS, LLC | 18.9K +18.9K (+100.0%) | 916.9K +916.9K (+100.0%) | 0.05% +0.051 pp | 0.18% +0.181 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 83 | METLIFE INVESTMENT MANAGEMENT, LLC | 18.5K +— (+0.0%) | 908.6K +15.2K (+1.7%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD20.32 +141.1% | 11 qtrs — |
| 84 | D. E. SHAW & CO., INC. | 18.0K +18.0K (+100.0%) | 882.0K +882.0K (+100.0%) | 0.05% +0.049 pp | 0.00% +0.001 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 85 | FINEMARK NATIONAL BANK & TRUST | 17.4K -5.3K (-23.3%) | 854.1K -241.1K (-22.0%) | 0.05% -0.015 pp | 0.03% -0.009 pp | USD4.66 +951.5% | 28 qtrs — |
| 86 | SEI INVESTMENTS CO | 17.3K +17.3K (+100.0%) | 849.0K +849.0K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.001 pp | USD49.00 +0.0% | 1 qtrs NEW |
| 87 | QUANTBOT TECHNOLOGIES LP | 17.0K +74.0 (+0.4%) | 833.8K +17.5K (+2.1%) | 0.05% 0.000 pp | 0.03% +0.006 pp | USD38.88 +26.0% | 3 qtrs — |
| 88 | LOS ANGELES CAPITAL MANAGEMENT LLC | 21.9K -6.8K (-23.6%) | 824.0K -558.9K (-40.4%) | 0.06% -0.019 pp | 0.00% -0.002 pp | USD24.93 +96.6% | 7 qtrs — |
| 89 | ROUND ROCK ADVISORS, LLC | 17.4K +7.0K (+67.7%) | 656.5K +156.1K (+31.2%) | 0.05% +0.019 pp | 0.10% +0.019 pp | USD48.51 +1.0% | 2 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 101 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.73% | 8.17M | 0.35% |
| 2 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.36% | 83.9K | 1.22% |
| 3 | iShares U.S. Pharmaceuticals ETF IHE | 0.32% | 4.25M | 0.38% |
| 4 | iShares Micro-Cap ETF IWC | 0.31% | 4.61M | 0.60% |
| 5 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.13% | 1.37M | 0.20% |
| 6 | Principal U.S. Small-Cap Multi-Factor ETF PSC | 0.13% | 1.70M | 0.38% |
| 7 | First Trust Small Cap Core AlphaDEX Fund FYX | 0.13% | 1.73M | 0.58% |
| 8 | American Century Small Cap Growth Insights ETF ACSG | 0.12% | 31.5K | 0.49% |
| 9 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.11% | 1.21M | 0.35% |
| 10 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.11% | 81.2K | 0.35% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.33
Bearish
Ratio by volume
0.18
Bearish
Buys
2
Sells
6
Shares acquired
40.0K
Shares disposed
223.6K
Cash buys
—
Cash sales
6.00
Net activity
-183,572
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 134,000 | 39.67 | 5.32M | 3,622,000 | I | ↗ |
| 2026-03-03 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 59,000 | 39.15 | 2.31M | 3,756,000 | I | ↗ |
| 2026-02-27 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 54.18 | 270.9K | 65,000 | I | ↗ |
| 2026-01-30 | Sullivan Patrick William | Officer | A-Award | A | RSU | 25,000 | 0.00 | — | 25,000 | D | ↗ |
| 2026-01-06 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 20,000 | 53.35 | 1.07M | 70,000 | I | ↗ |
| 2025-12-12 | BOLL ANDREW R. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 60,000 | 3.95 | 237.0K | 0 | D | ↗ |
| 2025-12-12 | BAUM MARK L | Director / Officer | F-InKind | D | Common Stock | 79,994 | 47.06 | 3.76M | 2,986,130 | D | ↗ |
| 2025-10-06 | Mullery Francis William Jr | Officer | — | — | Stock Option (Right to Buy) | 33,000 | 48.18 | 1.59M | 0 | D | ↗ |
| 2025-09-01 | Pollard Randall E. | Officer | A-Award | A | Stock Option (Right to Buy) | 30,000 | 39.00 | 1.17M | 30,000 | D | ↗ |
| 2025-07-21 | BAUM MARK L | Director / Officer / 10% Owner | M-Exempt | A | Common stock | 600,000 | 7.87 | 4.72M | 3,199,462 | D | ↗ |
| 2025-07-01 | BOLL ANDREW R. | Officer | A-Award | A | RSU | 405,750 | 0.00 | — | 405,750 | D | ↗ |
| 2025-07-01 | BAUM MARK L | Director / Officer | A-Award | A | RSU | 889,500 | 0.00 | — | 889,500 | D | ↗ |
| 2025-06-20 | Sternberg Perry J. | Director | A-Award | A | RSU | 7,339 | 0.00 | — | 7,339 | D | ↗ |
| 2025-06-20 | SILVERNAIL LAUREN P | Director | A-Award | A | RSU | 7,339 | 0.00 | — | 7,339 | D | ↗ |
| 2025-06-20 | Graves Adrienne L | Director | A-Award | A | RSU | 7,339 | 0.00 | — | 7,339 | D | ↗ |
| 2025-06-10 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 15,000 | 30.80 | 462.0K | 90,000 | I | ↗ |
| 2025-06-09 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 15,204 | 30.37 | 461.8K | 105,000 | I | ↗ |
| 2025-06-04 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 1,796 | 30.02 | 53.9K | 120,204 | I | ↗ |
| 2025-06-03 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 3,000 | 30.04 | 90.1K | 122,000 | I | ↗ |
| 2025-05-13 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 26.59 | 132.9K | 125,000 | I | ↗ |
| 2025-05-12 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 10,000 | 25.90 | 259.0K | 130,000 | I | ↗ |
| 2025-04-07 | SAHAREK JOHN P. | Officer | F-InKind | D | Common Stock | 109,475 | 23.09 | 2.53M | 467,388 | D | ↗ |
| 2025-04-07 | BOLL ANDREW R. | Officer | F-InKind | D | Common Stock | 136,745 | 23.09 | 3.16M | 777,844 | D | ↗ |
| 2025-04-07 | BAUM MARK L | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 300,363 | 23.09 | 6.94M | 2,599,462 | D | ↗ |
| 2025-04-03 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common Stock | 277,200 | 0.00 | — | 576,863 | D | ↗ |
| 2025-04-03 | BOLL ANDREW R. | Officer | M-Exempt | A | Common Stock | 346,500 | 0.00 | — | 914,589 | D | ↗ |
| 2025-04-03 | BAUM MARK L | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 762,300 | 0.00 | — | 2,899,825 | D | ↗ |
| 2025-03-24 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 30.01 | 150.1K | 140,000 | I | ↗ |
| 2025-03-18 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 30.01 | 150.1K | 140,000 | I | ↗ |
| 2025-02-28 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 28.05 | 140.3K | 150,000 | I | ↗ |
| 2025-01-22 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 20,000 | 35.59 | 711.8K | 155,000 | I | ↗ |
| 2025-01-06 | Shojaei Amir | Officer | A-Award | A | Stock Option (Right to Buy) | 30,000 | 35.96 | 1.08M | 30,000 | D | ↗ |
| 2024-09-11 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common stock | 90,000 | 7.37 | 663.3K | 344,803 | — | ↗ |
| 2024-06-14 | Sternberg Perry J. | Director | A-Award | A | RSU | 8,347 | 0.00 | — | 8,347 | — | ↗ |
| 2024-06-14 | SILVERNAIL LAUREN P | Director | A-Award | A | RSU | 8,347 | 0.00 | — | 8,347 | — | ↗ |
| 2024-06-14 | Makary Martin A. | Director | A-Award | A | RSU | 8,347 | 0.00 | — | 8,347 | — | ↗ |
| 2024-06-14 | Graves Adrienne L | Director | A-Award | A | RSU | 8,347 | 0.00 | — | 8,347 | — | ↗ |
| 2024-04-25 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 20,000 | 9.97 | 199.4K | 3,815,000 | — | ↗ |
| 2024-04-24 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 8,285 | 10.15 | 84.1K | 3,795,000 | — | ↗ |
| 2024-04-23 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 11,715 | 10.29 | 120.5K | 3,786,715 | — | ↗ |
| 2024-04-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 29,400 | 10.56 | 310.4K | 3,775,000 | — | ↗ |
| 2024-03-28 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 50,000 | 12.82 | 641.0K | 3,745,600 | — | ↗ |
| 2024-03-22 | BAUM MARK L | Director / Officer | P-Purchase | A | Common stock | 9,000 | 11.59 | 104.3K | 2,137,525 | — | ↗ |
| 2024-03-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 50,600 | 9.65 | 488.3K | 3,695,600 | — | ↗ |
| 2024-03-01 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common stock | 5,000 | 8.75 | 43.8K | 254,803 | — | ↗ |
| 2024-02-20 | SAHAREK JOHN P. | Officer | M-Exempt | D | RSU | 30,000 | 0.00 | — | 0 | — | ↗ |
| 2024-02-20 | BOLL ANDREW R. | Officer | M-Exempt | D | Common stock | 18,480 | 10.67 | 197.2K | 568,089 | — | ↗ |
| 2024-02-20 | BAUM MARK L | Director / Officer | M-Exempt | D | RSU | 150,000 | 0.00 | — | 0 | — | ↗ |
| 2024-02-07 | BOLL ANDREW R. | Officer | M-Exempt | A | Common stock | 7,400 | 7.71 | 57.1K | 541,569 | — | ↗ |
| 2024-02-07 | BAUM MARK L | Director / Officer | M-Exempt | A | Common stock | 15,400 | 7.71 | 118.7K | 2,038,361 | — | ↗ |
| 2024-01-26 | SILVERNAIL LAUREN P | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-26 | Graves Adrienne L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-16 | BAUM MARK L | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 8.11 | 60.8K | 2,022,961 | — | ↗ |
| 2023-11-15 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 8.03 | 200.7K | 3,645,000 | — | ↗ |
| 2023-11-10 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 242,197 | — | ↗ |
| 2023-09-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,983 | 14.49 | 86.7K | 3,620,000 | — | ↗ |
| 2023-09-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 14,017 | 14.65 | 205.4K | 3,614,017 | — | ↗ |
| 2023-08-14 | Makary Martin A. | Director | P-Purchase | A | Common Stock | 20,000 | 16.92 | 338.4K | 45,000 | — | ↗ |
| 2023-08-14 | BAUM MARK L | Director / Officer | P-Purchase | A | Common Stock | 5,800 | 17.05 | 98.9K | 2,015,461 | — | ↗ |
| 2023-07-18 | SAHAREK JOHN P. | Officer | F-InKind | D | Common Stock | 109,080 | 18.23 | 1.99M | 222,197 | — | ↗ |
| 2023-07-18 | BOLL ANDREW R. | Officer | M-Exempt | D | Performance Stock Unit | 346,500 | 0.00 | — | 0 | — | ↗ |
| 2023-07-18 | BAUM MARK L | Director / Officer | F-InKind | D | Common Stock | 299,968 | 18.23 | 5.47M | 2,009,661 | — | ↗ |
| 2023-06-21 | Van Horn R. Lawrence | Director | A-Award | A | RSU | 7,744 | 0.00 | — | 7,744 | — | ↗ |
| 2023-06-21 | Sternberg Perry J. | Director | A-Award | A | RSU | 7,744 | 0.00 | — | 7,744 | — | ↗ |
| 2023-06-21 | Sparks Teresa | Director | A-Award | A | RSU | 7,744 | 0.00 | — | 7,744 | — | ↗ |
| 2023-06-21 | Makary Martin A. | Director | A-Award | A | RSU | 7,744 | 0.00 | — | 7,744 | — | ↗ |
| 2023-04-03 | SAHAREK JOHN P. | Officer | A-Award | A | Restricted Stock Unit | 277,200 | 0.00 | — | 277,200 | — | ↗ |
| 2023-04-03 | BOLL ANDREW R. | Officer | A-Award | A | Restricted Stock Unit | 346,500 | 0.00 | — | 346,500 | — | ↗ |
| 2023-04-03 | BAUM MARK L | Director / Officer | A-Award | A | Restricted Stock Unit | 762,300 | 0.00 | — | 762,300 | — | ↗ |
| 2023-03-31 | BOLL ANDREW R. | Officer | M-Exempt | A | Common Stock | 90,000 | 6.00 | 540.0K | 358,461 | — | ↗ |
| 2023-01-02 | BOLL ANDREW R. | Officer | M-Exempt | A | Common Stock | 23,000 | 0.00 | — | 278,063 | — | ↗ |
| 2023-01-02 | BAUM MARK L | Officer | M-Exempt | A | Common Stock | 88,000 | 0.00 | — | 1,520,141 | — | ↗ |
| 2022-12-22 | Van Horn R. Lawrence | Director | P-Purchase | A | Common Stock | 1,860 | 13.42 | 25.0K | 1,860 | — | ↗ |
| 2022-12-22 | BOLL ANDREW R. | Officer | P-Purchase | A | Common Stock | 2,500 | 13.54 | 33.9K | 255,063 | — | ↗ |
| 2022-12-22 | BAUM MARK L | Officer | P-Purchase | A | Common Stock | 25,000 | 13.39 | 334.8K | 1,432,141 | — | ↗ |
| 2022-12-21 | Makary Martin A. | Director | P-Purchase | A | Common Stock | 25,000 | 13.37 | 334.3K | 25,000 | — | ↗ |
| 2022-12-14 | Opaleye Management Inc. | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 16,183 | 10.52 | 170.2K | 175,000 | — | ↗ |
| 2022-09-30 | LINDSTROM RICHARD L MD | Director | S-Sale | D | Common Stock | 40,000 | 12.62 | 504.8K | 26,100 | — | ↗ |
| 2022-09-28 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 9.77 | 97.7K | 3,185,000 | — | ↗ |
| 2022-06-09 | Van Horn R. Lawrence | Director | A-Award | A | RSU | 13,123 | 0.00 | — | 13,123 | — | ↗ |
| 2022-06-09 | Sternberg Perry J. | Director | A-Award | A | RSU | 13,123 | 0.00 | — | 13,123 | — | ↗ |
| 2022-06-09 | Sparks Teresa | Director | A-Award | A | RSU | 13,123 | 0.00 | — | 13,123 | — | ↗ |
| 2022-06-09 | Makary Martin A. | Director | A-Award | A | RSU | 13,123 | 0.00 | — | 13,123 | — | ↗ |
| 2022-06-09 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 13,123 | 0.00 | — | 13,123 | — | ↗ |
| 2022-04-13 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 6.76 | 67.6K | 3,175,000 | — | ↗ |
| 2022-04-12 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 6.75 | 168.7K | 3,165,000 | — | ↗ |
| 2022-03-31 | Sternberg Perry J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-31 | Makary Martin A. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-19 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-02-19 | BOLL ANDREW R. | Officer | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 273,168 | — | ↗ |
| 2022-01-28 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,000 | 6.89 | 34.4K | 3,140,000 | — | ↗ |
| 2022-01-20 | BAUM MARK L | Director / Officer | M-Exempt | A | Common Stock | 125,000 | 2.40 | 300.0K | 1,478,547 | — | ↗ |
| 2021-09-24 | LINDSTROM RICHARD L MD | Director | S-Sale | D | Common Stock | 3,900 | 10.04 | 39.2K | 66,100 | — | ↗ |
| 2021-09-16 | LINDSTROM RICHARD L MD | Director | S-Sale | D | Common Stock | 5,840 | 9.02 | 52.7K | 70,000 | — | ↗ |
| 2021-09-15 | LINDSTROM RICHARD L MD | Director | S-Sale | D | Common Stock | 14,160 | 9.09 | 128.7K | 75,840 | — | ↗ |
| 2021-08-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 50,000 | 8.45 | 422.3K | 3,135,000 | — | ↗ |
| 2021-08-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 45,000 | 8.64 | 389.0K | 3,085,000 | — | ↗ |
| 2021-08-17 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 25,000 | 8.57 | 214.2K | 3,040,000 | — | ↗ |
| 2021-07-23 | SAHAREK JOHN P. | Officer | A-Award | A | Restricted Stock Unit | 277,200 | 0.00 | — | 277,200 | — | ↗ |
| 2021-07-23 | BOLL ANDREW R. | Officer | A-Award | A | Restricted Stock Unit | 346,500 | 0.00 | — | 346,500 | — | ↗ |
| 2021-07-23 | BAUM MARK L | Director / Officer | A-Award | A | Restricted Stock Unit | 762,301 | 0.00 | — | 762,301 | — | ↗ |
| 2021-07-21 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 4,500 | 7.60 | 34.2K | 3,015,000 | — | ↗ |
| 2021-07-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 125 | 7.20 | 899.99 | 140,294 | — | ↗ |
| 2021-07-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 5,700 | 6.97 | 39.7K | 3,005,700 | — | ↗ |
| 2021-06-25 | Van Horn R. Lawrence | Director | A-Award | A | RSU | 9,644 | 0.00 | — | 9,644 | — | ↗ |
| 2021-06-25 | Sparks Teresa | Director | A-Award | A | RSU | 9,644 | 0.00 | — | 9,644 | — | ↗ |
| 2021-06-25 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 9,644 | 0.00 | — | 9,644 | — | ↗ |
| 2021-06-25 | Kammer Robert J | Director | A-Award | A | RSU | 9,644 | 0.00 | — | 9,644 | — | ↗ |
| 2021-06-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 59,800 | 8.35 | 499.3K | 3,000,000 | — | ↗ |
| 2021-06-17 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 10,800 | 8.32 | 89.9K | 2,940,200 | — | ↗ |
| 2021-05-20 | LINDSTROM RICHARD L MD | Director | S-Sale | D | Common Stock | 10,000 | 10.75 | 107.5K | 90,000 | — | ↗ |
| 2021-04-25 | BOLL ANDREW R. | Officer | M-Exempt | D | Restricked Stock Unit | 127,500 | 0.00 | — | 0 | — | ↗ |
| 2021-04-25 | BAUM MARK L | Director / Officer | F-InKind | D | Common Stock | 334,129 | 8.26 | 2.76M | 1,353,547 | — | ↗ |
| 2021-02-25 | BOLL ANDREW R. | Officer | M-Exempt | D | Restricted Stock Unit | 30,000 | 0.00 | — | 127,500 | — | ↗ |
| 2021-02-25 | BAUM MARK L | Director / Officer | M-Exempt | A | Common Stock | 200,000 | 0.00 | — | 837,676 | — | ↗ |
| 2021-02-19 | SAHAREK JOHN P. | Officer | A-Award | A | Restricted Stock Unit | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2021-02-19 | BOLL ANDREW R. | Officer | A-Award | A | Restricted Stock Unit | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2021-02-19 | BAUM MARK L | Director / Officer | A-Award | A | Restricted Stock Unit | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2020-12-22 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 15,900 | 5.19 | 82.6K | 2,929,400 | — | ↗ |
| 2020-12-21 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 51,400 | 5.24 | 269.3K | 2,913,500 | — | ↗ |
| 2020-12-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 35,000 | 5.31 | 185.9K | 2,862,100 | — | ↗ |
| 2020-09-28 | Van Horn R. Lawrence | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-28 | Principi Anthony | Director | M-Exempt | D | RSU | 34,091 | 0.00 | — | 60,812 | — | ↗ |
| 2020-07-12 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 19,000 | 4.99 | 94.8K | 2,827,100 | — | ↗ |
| 2020-07-11 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 46,800 | 4.96 | 231.9K | 2,808,100 | — | ↗ |
| 2020-07-10 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 45,000 | 4.98 | 224.0K | 2,761,300 | — | ↗ |
| 2020-07-09 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 25,000 | 4.84 | 121.0K | 2,716,300 | — | ↗ |
| 2020-07-08 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 65,000 | 4.99 | 324.6K | 2,691,300 | — | ↗ |
| 2020-07-07 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 41,300 | 5.18 | 214.0K | 2,626,300 | — | ↗ |
| 2020-06-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 35,000 | 5.58 | 195.4K | 2,585,000 | — | ↗ |
| 2020-06-04 | Sparks Teresa | Director | A-Award | A | RSU | 17,006 | 0.00 | — | 17,006 | — | ↗ |
| 2020-06-04 | Principi Anthony | Director | A-Award | A | RSU | 17,006 | 0.00 | — | 17,006 | — | ↗ |
| 2020-06-04 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 10,000 | 5.79 | 57.9K | 2,550,000 | — | ↗ |
| 2020-06-04 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 17,006 | 0.00 | — | 17,006 | — | ↗ |
| 2020-06-04 | Kammer Robert J | Director | A-Award | A | RSU | 17,006 | 0.00 | — | 17,006 | — | ↗ |
| 2020-06-04 | BAUM MARK L | Director / Officer | D-Return | D | Employee Stock Option - Right to Buy | 600,000 | 7.87 | 4.72M | 0 | — | ↗ |
| 2020-06-03 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 20,600 | 5.74 | 118.3K | 2,540,000 | — | ↗ |
| 2020-06-02 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 19,400 | 5.69 | 110.3K | 2,519,400 | — | ↗ |
| 2020-05-22 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 8,804 | 5.05 | 44.5K | 2,500,000 | — | ↗ |
| 2020-05-21 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 200 | 4.70 | 939.62 | 120,000 | — | ↗ |
| 2020-05-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 1,200 | 4.50 | 5.4K | 119,800 | — | ↗ |
| 2020-05-14 | Opaleye Management Inc. | 10% Owner | — | I | Common Stock, $0.001 par value | 0 | 0.00 | — | 2,480,500 | — | ↗ |
| 2020-03-16 | Sparks Teresa | Director | A-Award | A | RSU | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2020-03-16 | AUSTIN STEPHEN G | Director | M-Exempt | A | COMMON STOCK | 72,218 | 0.00 | — | 91,987 | — | ↗ |
| 2020-01-02 | BOLL ANDREW R. | Officer | A-Award | A | Option - Right to Buy | 57,000 | 7.30 | 416.1K | 57,000 | — | ↗ |
| 2020-01-02 | BAUM MARK L | Director / Officer | A-Award | D | Option - Right to Buy | 217,500 | 7.30 | 1.59M | 217,500 | — | ↗ |
| 2019-11-22 | BOLL ANDREW R. | Officer | X-InTheMoney | A | Common Stock | 39,000 | 1.79 | 69.8K | 123,000 | — | ↗ |
| 2019-11-22 | BAUM MARK L | Director / Officer | X-InTheMoney | A | Common Stock | 156,000 | 1.79 | 279.2K | 598,126 | — | ↗ |
| 2019-11-11 | Kammer Robert J | Director | S-Sale | D | Common Stock | 6,500 | 4.75 | 30.9K | 797,327 | — | ↗ |
| 2019-10-07 | Kammer Robert J | Director | S-Sale | D | Common Stock | 6,500 | 5.25 | 34.1K | 803,827 | — | ↗ |
| 2019-09-09 | Kammer Robert J | Director | S-Sale | D | Common Stock | 6,500 | 5.67 | 36.9K | 810,327 | — | ↗ |
| 2019-08-12 | Kammer Robert J | Director | S-Sale | D | Common Stock | 6,500 | 6.89 | 44.8K | 816,827 | — | ↗ |
| 2019-07-15 | Kammer Robert J | Director | S-Sale | D | Common Stock | 6,500 | 7.91 | 51.4K | 823,327 | — | ↗ |
| 2019-06-26 | Principi Anthony | Director | A-Award | A | RSU | 9,715 | 0.00 | — | 9,715 | — | ↗ |
| 2019-06-26 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 9,715 | 0.00 | — | 9,715 | — | ↗ |
| 2019-06-26 | Kammer Robert J | Director | A-Award | A | RSU | 9,715 | 0.00 | — | 9,715 | — | ↗ |
| 2019-06-26 | AUSTIN STEPHEN G | Director | A-Award | A | RSU | 9,715 | 0.00 | — | 9,715 | — | ↗ |
| 2019-06-03 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 5.78 | 57.8K | 829,827 | — | ↗ |
| 2019-05-01 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 4.57 | 45.7K | 839,827 | — | ↗ |
| 2019-04-01 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 4.77 | 47.7K | 849,827 | — | ↗ |
| 2019-03-01 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 6.91 | 69.1K | 859,827 | — | ↗ |
| 2019-02-19 | SAHAREK JOHN P. | Officer | A-Award | A | Option - Right to Buy | 50,000 | 6.30 | 315.0K | 50,000 | — | ↗ |
| 2019-02-19 | BOLL ANDREW R. | Officer | A-Award | A | Restricted Stock Unit | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2019-02-19 | BAUM MARK L | Director / Officer | A-Award | A | Option - Right to Buy | 150,000 | 6.30 | 945.0K | 150,000 | — | ↗ |
| 2019-02-01 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 5.86 | 58.6K | 869,827 | — | ↗ |
| 2019-01-02 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 5.33 | 53.3K | 879,827 | — | ↗ |
| 2018-12-03 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 4.64 | 46.4K | 889,827 | — | ↗ |
| 2018-11-01 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 4.21 | 42.1K | 899,827 | — | ↗ |
| 2018-10-15 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 3.00 | 30.0K | 909,827 | — | ↗ |
| 2018-09-04 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 3.00 | 30.0K | 919,827 | — | ↗ |
| 2018-08-10 | Kammer Robert J | Director | S-Sale | D | Common Stock | 130,000 | 3.00 | 390.0K | 929,827 | — | ↗ |
| 2018-06-29 | Principi Anthony | Director | A-Award | A | RSU | 34,091 | 0.00 | — | 34,091 | — | ↗ |
| 2018-06-29 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 34,091 | 0.00 | — | 34,091 | — | ↗ |
| 2018-06-29 | Kammer Robert J | Director | A-Award | A | RSU | 34,091 | 0.00 | — | 34,091 | — | ↗ |
| 2018-06-29 | AUSTIN STEPHEN G | Director | A-Award | A | RSU | 34,091 | 0.00 | — | 34,091 | — | ↗ |
| 2018-02-01 | SAHAREK JOHN P. | Officer | M-Exempt | A | Common Stock | 30,000 | 1.83 | 54.9K | 30,000 | — | ↗ |
| 2018-02-01 | BOLL ANDREW R. | Officer | M-Exempt | A | Common Stock | 30,000 | 1.83 | 54.9K | 84,000 | — | ↗ |
| 2018-01-02 | SAHAREK JOHN P. | Officer | A-Award | A | Option - Right to Buy | 50,000 | 1.73 | 86.5K | 50,000 | — | ↗ |
| 2018-01-02 | BOLL ANDREW R. | Officer | A-Award | A | Option - Right to Buy | 50,000 | 1.73 | 86.5K | 50,000 | — | ↗ |
| 2018-01-02 | BAUM MARK L | Director / Officer | A-Award | A | Option - Right to Buy | 150,000 | 1.73 | 259.5K | 150,000 | — | ↗ |
| 2017-07-17 | Kammer Robert J | Director | S-Sale | D | Common Stock | 10,000 | 3.05 | 30.5K | 1,059,827 | — | ↗ |
| 2017-06-13 | Principi Anthony | Director | A-Award | A | RSU | 15,723 | 0.00 | — | 15,723 | — | ↗ |
| 2017-06-13 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 15,723 | 0.00 | — | 15,723 | — | ↗ |
| 2017-06-13 | Kammer Robert J | Director | A-Award | A | RSU | 15,723 | 0.00 | — | 15,723 | — | ↗ |
| 2017-06-13 | AUSTIN STEPHEN G | Director | A-Award | A | RSU | 15,723 | 0.00 | — | 15,723 | — | ↗ |
| 2017-04-27 | LINDSTROM RICHARD L MD | Director | X-InTheMoney | D | Purchase Warrant | 100,000 | 1.79 | 179.0K | 0 | — | ↗ |
| 2017-04-13 | Edwards Clayton D | Officer | A-Award | A | Option - Right to Buy | 55,000 | 3.77 | 207.4K | 55,000 | — | ↗ |
| 2017-03-21 | Longboard Capital Advisors, LLC | — | P-Purchase | A | Warrants | 52,000 | 1.79 | 93.1K | 1,416,000 | — | ↗ |
| 2017-03-09 | Kammer Robert J | Director | J-Other | D | Common Stock | 20,000 | 0.00 | — | 1,069,827 | — | ↗ |
| 2017-02-01 | SAHAREK JOHN P. | Officer | A-Award | A | Option - Right to Buy | 55,000 | 2.23 | 122.7K | 55,000 | — | ↗ |
| 2017-02-01 | BOLL ANDREW R. | Officer | A-Award | A | Option - Right to Buy | 55,000 | 2.23 | 122.7K | 55,000 | — | ↗ |
| 2017-02-01 | BAUM MARK L | Director / Officer | A-Award | A | Option - Right to Buy | 160,000 | 2.23 | 356.8K | 160,000 | — | ↗ |
| 2016-12-19 | LINDSTROM RICHARD L MD | Director | P-Purchase | A | Common Stock | 100,000 | 1.79 | 179.0K | 100,000 | — | ↗ |
| 2016-12-19 | BOLL ANDREW R. | Officer | P-Purchase | A | Purchase Warrant | 39,000 | 1.79 | 69.8K | 39,000 | — | ↗ |
| 2016-12-19 | BAUM MARK L | Director / Officer | M-Exempt | A | Common Stock | 200,000 | 1.72 | 344.0K | 525,835 | — | ↗ |
| 2016-11-02 | Kammer Robert J | Director | J-Other | A | Common Stock | 95,000 | 4.58 | 435.1K | 1,089,827 | — | ↗ |
| 2016-06-10 | Principi Anthony | Director | A-Award | A | RSU | 12,690 | 0.00 | — | 12,690 | — | ↗ |
| 2016-06-10 | Nelson William H. | Director | A-Award | A | RSU | 12,690 | 0.00 | — | 12,690 | — | ↗ |
| 2016-06-10 | LINDSTROM RICHARD L MD | Director | A-Award | A | RSU | 12,690 | 0.00 | — | 12,690 | — | ↗ |
| 2016-06-10 | Kammer Robert J | Director | A-Award | A | RSU | 12,690 | 0.00 | — | 12,690 | — | ↗ |
Executive team
Top executives
EBIT / Employee
95.3K
Shares Outstanding
37.27M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Mark L. Baum Chief Executive Officer | 731.1K | — | — | — | 611.6K | 15.8K | 1.36M | 0.00% | ↗ |
| 2 | 2024 | Andrew R. Boll Chief Financial Officer and Corporate Secretary | 491.9K | — | — | — | 342.9K | 14.4K | 849.2K | 0.00% | ↗ |
| 3 | 2024 | John P. Saharek President and Chief Executive Officer, ImprimisRx | 463.4K | — | — | — | 234.0K | 46.0K | 743.5K | 0.00% | ↗ |
| 4 | 2023 | Mark L. Baum Chief Executive Officer | 680.1K | — | 14.15M | — | 421.8K | 3.8K | 15.26M | 92.75% | ↗ |
| 5 | 2023 | Andrew R. Boll Chief Financial Officer and Corporate Secretary | 459.9K | — | 6.43M | — | 236.5K | 1.8K | 7.13M | 90.21% | ↗ |
| 6 | 2023 | John P. Saharek President and Chief Executive Officer, ImprimisRx | 431.5K | — | 5.15M | — | 225.0K | 12.9K | 5.82M | 88.49% | ↗ |
| 7 | 2023 | John P. Saharek Chief Commercial Officer; Chief Executive Officer and President, ImprimisRx | 431.5K | — | 5.15M | — | 225.0K | 12.9K | 5.82M | 88.49% | ↗ |
| 8 | 2022 | Mark L. Baum Chief Executive Officer | 608.6K | — | — | — | 500.3K | 86.1K | 1.20M | 0.00% | ↗ |
| 9 | 2022 | Andrew R. Boll Chief Financial Officer and Corporate Secretary | 416.4K | — | — | — | 285.2K | 62.7K | 764.4K | 0.00% | ↗ |
| 10 | 2022 | John P. Saharek Chief Commercial Officer; Chief Executive Officer and President, ImprimisRx | 379.0K | — | — | — | 261.3K | 16.6K | 656.9K | 0.00% | ↗ |
| 11 | 2022 | John P. Saharek Chief Commercial Officer and President, ImprimisRx | 379.0K | — | — | — | 261.3K | 16.6K | 656.9K | 0.00% | ↗ |
| 12 | 2021 | Mark L. Baum Chief Executive Officer | 564.6K | — | 6.25M | — | 492.5K | 12.5K | 7.32M | 85.39% | ↗ |
| 13 | 2021 | Andrew R. Boll Chief Financial Officer and Corporate Secretary | 405.1K | — | 2.64M | — | 299.7K | 12.0K | 3.35M | 78.62% | ↗ |
| 14 | 2021 | John P. Saharek President, ImprimisRx | 347.3K | — | 2.05M | — | 261.8K | 12.8K | 2.68M | 76.77% | ↗ |
| 15 | 2021 | John P. Saharek Chief Commercial Officer and President, ImprimisRx | 347.3K | — | 2.05M | — | 261.8K | 12.8K | 2.68M | 76.77% | ↗ |
| 16 | 2020 | Mark L. Baum Chief Executive Officer | 569.8K | — | 696.7K | 948.3K | 256.1K | 12.4K | 2.48M | 66.24% | ↗ |
| 17 | 2020 | Andrew R. Boll Chief Financial Officer and Corporate Secretary | 409.7K | — | 193.3K | 248.5K | 153.1K | 12.2K | 1.02M | 43.45% | ↗ |
| 18 | 2020 | Andrew R. Boll Chief Financial Officer | 409.7K | — | 193.3K | 248.5K | 153.1K | 12.2K | 1.02M | 43.45% | ↗ |
| 19 | 2020 | John P. Saharek President, ImprimisRx | 316.7K | — | — | 87.4K | 118.3K | 11.1K | 533.5K | 16.38% | ↗ |
| 20 | 2019 | Mark L. Baum Chief Executive Officer | 488.6K | — | 18.1K | 556.1K | 297.8K | 16.4K | 1.38M | 41.70% | ↗ |
| 21 | 2019 | Andrew R. Boll Chief Financial Officer | 348.4K | — | 324.1K | 185.4K | 178.7K | 13.0K | 1.05M | 48.54% | ↗ |
| 22 | 2019 | John P. Saharek President, ImprimisRx | 290.1K | — | 315.1K | 185.4K | 156.3K | 16.9K | 963.8K | 51.93% | ↗ |
| 23 | 2018 | Mark L. Baum Chief Executive Officer | 410.7K | — | 4.4K | 204.0K | 425.0K | 13.1K | 1.06M | 19.71% | ↗ |
| 24 | 2018 | John P. Saharek Chief Commercial Officer | 275.2K | — | — | 68.1K | 224.8K | 11.9K | 580.1K | 11.74% | ↗ |
| 25 | 2018 | John P. Saharek President, ImprimisRx | 275.2K | — | — | 68.1K | 224.8K | 11.9K | 580.1K | 11.74% | ↗ |
| 26 | 2018 | Andrew R. Boll Chief Financial Officer | 264.6K | — | 2.2K | 68.0K | 203.9K | 12.5K | 551.2K | 12.73% | ↗ |
| 27 | 2017 | Mark L. Baum Chief Executive Officer | 417.3K | — | 154.8K | 303.4K | 36.0K | 1.5K | 913.0K | 50.18% | ↗ |
| 28 | 2017 | Andrew R. Boll Chief Financial Officer | 285.8K | — | 77.4K | 104.3K | 45.1K | 11.7K | 524.2K | 34.66% | ↗ |
| 29 | 2017 | John P. Saharek Chief Commercial Officer | 267.2K | — | — | 108.8K | 46.9K | 11.2K | 434.0K | 25.06% | ↗ |
| 30 | 2016 | Mark L. Baum Chief Executive Officer | 372.4K | — | 2.07M | 544.9K | 153.0K | 10.6K | 3.15M | 83.00% | ↗ |
| 31 | 2016 | Andrew R. Boll Chief Financial Officer | 234.1K | — | 531.7K | 192.4K | 84.7K | 7.4K | 1.05M | 68.94% | ↗ |
| 32 | 2016 | John P. Saharek Chief Commercial Officer | 247.3K | — | — | 192.4K | 102.6K | 8.6K | 550.9K | 34.93% | ↗ |
| 33 | 2015 | Mark L. Baum Chief Executive Officer | 338.9K | — | — | 2.78M | 114.4K | 10.6K | 3.25M | 85.72% | ↗ |
| 34 | 2015 | John P. Saharek Chief Commercial Officer | 201.3K | — | 221.1K | 534.6K | 66.0K | 8.1K | 1.03M | 73.29% | ↗ |
| 35 | 2015 | Andrew R. Boll Chief Financial Officer | 196.2K | — | 449.6K | — | 80.0K | 10.6K | 736.3K | 61.05% | ↗ |
| 36 | 2014 | Mark L. Baum Chief Executive Officer | 327.5K | — | — | 94.7K | 204.0K | 7.8K | 634.0K | 14.94% | ↗ |
| 37 | 2014 | Andrew R. Boll Chief Financial Officer | 154.1K | — | — | 45.5K | 95.0K | 6.0K | 300.6K | 15.14% | ↗ |
| 38 | 2012 | Mark L. Baum, J.D. Chief Executive Officer | 150.3K | — | 520.0K | 655.8K | — | — | 1.33M | 88.67% | ↗ |
| 39 | 2012 | Balbir Brar, D.V.M., Ph.D. Former President | 84.0K | — | — | 669.3K | — | — | 753.3K | 88.85% | ↗ |
| 40 | 2012 | Joachim P.H. Schupp, M.D. Chief Medical Officer | 178.5K | — | — | 260.1K | — | 29.1K | 467.7K | 55.61% | ↗ |
| 41 | 2012 | Andrew R. Boll Vice-President, Accounting and Public Reporting | 64.5K | — | — | 51.8K | — | 7.5K | 123.8K | 41.82% | ↗ |
| 42 | 2012 | Andrew R. Boll, CMA Vice-President, Accounting and Public Reporting | 64.5K | — | — | 51.8K | — | 7.5K | 123.8K | 41.82% | ↗ |
| 43 | 2011 | Joachim P.H. Schupp, M.D. Chief Medical Officer | 38.8K | — | — | 2.2K | — | — | 41.0K | 5.35% | ↗ |
| 44 | 2011 | Andrew R. Boll Vice-President, Accounting and Public Reporting | — | — | — | — | — | — | — | — | ↗ |
| 45 | 2011 | Andrew R. Boll, CMA Vice-President, Accounting and Public Reporting | — | — | — | — | — | — | — | — | ↗ |
| 46 | 2011 | Mark L. Baum, J.D. Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 47 | 2011 | Balbir Brar, D.V.M., Ph.D. Former President | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark L. Baum | CEO, Chairman of the Board & Founder | 1M | male |
| Andrew R. Boll | President, Chief Financial Officer & Corporate Secretary | 849.2K | male |
| Kim Barratt | Chief Talent Officer | — | female |
| Mark A. Mannebach | Head of Regulatory Affairs & Pharmacovigilance | — | — |
| Michael D. Biega | Vice President of Investor Relations & Communications | — | male |
| Patrick W. Sullivan | Chief Commercial Officer | — | male |
| Prashanth S. Annavajjhala | Chief of Staff | — | — |
| Amir W. Shojaei | Chief Scientific Officer | — | — |
| Randall E. Pollard | Chief Accounting Officer | — | male |
| Brett A. Burrell | Vice President of Legal & Compliance | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HROW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
